Please ENTER to search

← Back

DMF Filings & Regulatory Approvals

USA

USFDA Audits: March 2015, March 2017, March 2018

US DMF: Homatropine Methyl bromide, Celecoxib, Atropine Sulfate (Active), Chlorzoxazone, Diethyl Carbamazine Citrate, Nitisinone, Probenecid, Dexketoprofen Trometamol

CEP

Atropine Sulfate, Ketoprofen (Filed & Under Registration), Levofloxacin Hemihydrate

WHO

WHO Geneva Empanelment

EU

EDMF: Dexketoprofen Trometamol, Homatropine Methyl bromide, Atropine Sulfate, Ketorolac Trometamol, Pregabalin, Levofloxacin Hemihydrate

Korea

MFDS: Dexketoprofen, Ketorolac Trometamol

Australia

TGA empaneled (Atropine Sulphate)

Russia

MOH registration (Ketorolac Trometamol) & Dexketoprofen Trometamol

Taiwan

FDA: Homatropine Methyl bromide, Atropine Sulphate, Levofloxacin Hemihydrate

Canada

Ketorolac Trometamol & Atropine Sulfate under registration

ANVISA

Homatropine Methyl Bromide, Ketorolac under registration

dots
Footer Form Banner

Ready to discuss your needs with us?

Request you to provide all details mentioned in the form along with your business requirement. It will help us route your query to the appropriate person.

Please enter a valid name (only alphabets and spaces allowed).
Please enter your organization name.
Please enter a valid work email address.
Please enter a valid phone number.
Please select your country.
Please enter your message.
You must agree to the privacy policy.